The global market for OTC medicines reached $US60bn in 2004. A growing percentage of this was outside of the traditional pharmacy channel. As markets liberalise, and OTCs become more widely available, IMS continues to invest in data acquisition to ensure we offer our customers the most complete and accurate picture of the global OTC market.
Our customers are facing a unique set of challenges and opportunities. We can help you understand the dynamics of this marketplace:
- Which countries, categories and retail channels offer the best opportunity for growth?
- What is driving the market? New launches, Rx-to-OTC switches, innovations in packaging and formulation?
- How can I measure the effectiveness of my A&P spend?
- What drives consumer purchasing behaviour?
- How are my products viewed by the pharmacist, and how does that affect recommendations of my brand?
- What will be impact of legislative changes such as de-listing and de-reimbursement on my brand? What lessons can be learned from other markets?
By combining our unique data assets with a strong understanding of the Consumer Health environment, IMS brings an evidence-based approach to answering these and other questions.
